Clinical Trial Update: A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)

View source ↗

Summary

This document summarizes results from a long-term registry of Humira (adalimumab) in patients with moderately to severely active Crohn's disease, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Crohn's Disease | Status: COMPLETED | Results posted: 2017-01-24